Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.

Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.

Deep in a forest in the West African country of Ghana, two men are searching for plants that they hope could ultimately provide a cure for some of the world’s deadliest diseases.

Novartis opens up a path of research to protect proteins that guard against cancer.

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.